
Loading, please wait...

Loading, please wait...

The medical procurement scam in Chhattisgarh has seen significant developments recently. The state’s Anti-Corruption Bureau (ACB) and Economic Offence Wing (EOW) filed a supplementary chargesheet against four key individuals. These individuals allegedly facilitated irregularities in the procurement of medical equipment and reagents during 2023. Consequently, the state exchequer suffered massive financial losses.
Investigation results show that the accused collaborated to manipulate the tender process. Specifically, firms like Mokshit Corporation and Shri Sharda Industries fabricated documents to secure contracts. Furthermore, these companies quoted identical prices for various consumables. They intentionally inflated the prices of essential items, including EDTA tubes and CBC machines. For instance, Mokshit Corporation sold EDTA tubes at Rs 2,352 each, despite the standard market rate of Rs 8.50. This blatant overpricing caused a loss of approximately Rs 550 crore to the government. Additionally, the firms supplied CBC machines at nearly triple their market value.
The ACB/EOW named officials from several prominent medical supply companies in the latest filing. These include representatives from Recorders and Medicare Systems and DiaSys India. Moreover, the investigation found that the companies fixed high maximum retail prices to deceive the Chhattisgarh Medical Services Corporation (CGMSC). Although the original FIR did not name specific individuals, the supplementary chargesheet provides a clearer picture of the collusion. Authorities continue to examine the roles of health department officials in this multi-billion rupee scandal.
Q1: What was the primary cause of the financial loss in the medical procurement scam?
The financial loss stemmed from the supply of reagents and equipment at prices significantly higher than the actual market rates, sometimes reaching three times the normal cost.
Q2: Which institutions were involved in the procurement irregularities?
The Chhattisgarh Medical Services Corporation and the Directorate of Health Services were the primary government bodies involved in the procurement from the accused private firms.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Chhattisgarh ACB/EOW files a supplementary chargesheet against four individuals for a Rs 550 crore medical equipment procurement scam involving Mokshit Corp...
6 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today